Tokyo, July 15 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058452) titled 'Development and Validation of a Predictive Index for Glycemic Control by Trends in Environmental Factors and Body Composition in Patients with Type 2 Diabetes Mellitus' on July 14.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Self control
Primary Sponsor:
Institute - Gunma Paz University
Condition:
Condition - Type 2 Diabetes Mellitus
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To develop and validate a synergistic behavioral prediction index (SBPI) combining 50 kHz reactance and neighborhood walking environment scores in newly diagnosed type 2 diabetic patients to assess its predictive accuracy for successful behavior change and achievement of glycemic control in lifestyle interventions.
Basic objectives2 - Others
Intervention:
Interventions/Control_1 - Standardized lifestyle intervention (dietary therapy + exercise therapy + education)
Eligibility:
Age-lower limit - 20
years-old
=
Gender - Male and Female
Key inclusion criteria - Newly diagnosed type 2 diabetes (within 3 months of diagnosis) Age 20-80 Baseline HbA1c 6.5-9.9% (48-85 mmol/mol) Available to participate in lifestyle intervention
Key exclusion criteria - Type 1 diabetes or secondary diabetes Pregnant or lactating Serious liver disease (ALT >3 times upper limit of normal) Heart failure (NYHA Class III-IV) Dialysis or eGFR <30 mL/min/1.73m^2 Contraindication to bioelectrical impedance measurement Not obtain informed consent
Target Size - 195
Recruitment Status:
Recruitment status - Completed
Date of protocol fixation - 2021 Year 06 Month 20 Day
Date of IRB - 2023 Year 06 Month 20 Day
Anticipated trial start date - 2022 Year 04 Month 01 Day
Last follow-up date - 2023 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066830
Disclaimer: Curated by HT Syndication.